This blog explores what LEAD means for the post-acute market, why “Preferred Provider” status will become more competitive, and how data transparency will determine strategic relevance. It also outlines how Trella Health equips providers with claims-backed insights, such as Total Cost of Care analytics and Hospice Timing Impact metrics, to quantify value, strengthen ACO partnerships, and compete successfully in the next era of value-based care. The LEAD model emphasizes sustainable benchmarks and other innovative policies to ensure long-term stability for provider organizations.
In March 2026, the Centers of Medicare and Medicaid (CMS) will release the Request for Applications for the Long-term Enhanced ACO Design (LEAD) Model: the 10-year successor to ACO REACH. The LEAD model aims to use improved benchmarking, prospective payments, and other innovative policies to attract a larger variety of provider organizations, including rural and independent practices.
For post-acute providers, LEAD represents more than a regulatory update. It’s a structural reset of how referral networks are formed, how performance is judged, and how financial viability is secured. The model is designed to support high-needs and underserved populations, ensuring that smaller, rural, and independent practices can participate and thrive.
The core question is no longer “Are we delivering good care?” It’s “Can we prove our impact on total cost of care?”
Below, we explore what LEAD means for the post-acute market and why Trella Health is uniquely positioned to help providers demonstrate their value and build strategic alignment.
What Is the CMS LEAD Model and Why Does It Matter for Post-Acute Care?
While CMS has not finalized the specific performance metrics, LEAD is designed to incentivize reductions in total cost of care, prevent unnecessary hospitalizations and emergency care, improve quality outcomes, and reward long‑term value creation through coordinated, accountable care. The LEAD model will hold ACOs accountable for clinically meaningful quality measures focused on prevention, chronic disease management, and high quality care.
Because post-acute providers directly influence these outcomes, they sit at the center of cost and quality performance under LEAD. The model incentivizes comprehensive management of chronic conditions and social determinants of health to improve population health.
The era of referral decisions based on geography or bed availability is ending. The era of measurable impact is here. The LEAD model features a focus on supporting high-needs patients, including high needs patients such as dual-eligibles and homebound individuals, as well as rural and independent practices.
What Strategic Decisions Will Post-Acute Providers Face in 2026?
As CMS opens applications, providers must determine whether to:
- Participate directly in an ACO
- Secure “Preferred Provider” status within an ACO network, as the model encourages the development of preferred providers through structured risk arrangements.
Both paths require one thing: proof.
Hospitals and ACOs will not rely on anecdotal quality claims. They will demand claims-backed evidence showing:
- Lower total cost of care
- Reduced readmissions
- Efficient length-of-stay management
- Effective hospice utilization timing
ACOs will also need to understand the details of the benchmark methodology to evaluate whether LEAD will fairly assess their performance over the model’s 10-year time frame. This is where data becomes critical.
How Can Providers Prove Their Value Under LEAD?
Under LEAD, providers will need to demonstrate measurable value to ACOs using data that reflect outcomes and cost impact. The LEAD model will incorporate more accurate risk adjustment to support ACOs serving high-risk and complex patients. This includes claims- and quality-based insights such as:
- Total Cost of Care (TCOC) impact
- Days at Home
- Readmission rates
- Emergency department utilization
- Hospice timing and end-of-life cost patterns
- Identification and monitoring of high-risk patients using digital tools and resources to enable early intervention and prevent avoidable readmissions
Effective communication and coordination between healthcare providers, supported by advanced tools, can improve patient outcomes and reduce readmissions.
What is the challenge?
Most providers lack accessible, patient-level claims data to quantify their downstream impact, especially across 30–180 day windows. The ACO LEAD model is heavily reliant on integrated data, real-time analytics, and advanced technology infrastructure to provide real-time insights for proactive intervention.
Without this visibility, providers are forced to rely on generalized quality metrics instead of value-based performance evidence. Real-time data and proactive outreach can help catch potential issues early and prevent complications.
How Does Trella Health Solve This?
Trella Health transforms Medicare claims data into actionable, provider-specific insight that aligns directly with LEAD accountability measures. Healthcare providers can use these insights to improve discharge planning and patient education, which can significantly reduce the likelihood of readmissions.
Through its Market Insights platform, Trella enables organizations to:
- Quantify their impact on total Medicare spend
- Benchmark performance against state and national averages
- Identify referral sources driving avoidable utilization
- Visualize patient-level cost and utilization patterns
Instead of saying “we reduce readmissions,” providers can demonstrate by how much and for which patient populations. That level of specificity changes conversations with ACO executives.
Why Is Hospice Timing Now a Strategic Lever Under LEAD?
End-of-life care is a significant driver of Medicare spend, and timely hospice enrollment can greatly influence both utilization and cost outcomes. Under LEAD, post-acute providers who can optimize hospice timing have a strategic opportunity to support ACO performance. Effective follow-up care after a hospital stay and addressing root causes of readmissions, including social determinants of health, are crucial for optimizing outcomes. Addressing social determinants of health can help prevent readmissions by ensuring patients have the resources they need to manage their health. The LEAD model will include Benefit Enhancements and Beneficiary Engagement Incentives to promote healthy living activities and support patients post-discharge.
Trella Health’s Hospice Timing Impact metrics, now available in its Marketscape Insights platform, brings unprecedented transparency to how the timing of hospice enrollment affects Medicare spend and utilization in the final 30–180 days of life.
What Does Hospice Timing Impact Metrics Show?
They provide:
- Claims-backed visualization of spend differences by hospice length of stay
- Hospital and ER utilization patterns tied to referral timing
- Patient-level insights filtered by health condition and time frame, such as 30-day, 90-day, or 180-day periods
- State and national benchmarking
These insights allow hospice providers to demonstrate that earlier enrollment:
- Reduces inpatient days
- Decreases avoidable readmissions
- Lowers overall Medicare spend
- Improves patient experience
For ACOs operating under LEAD, this data becomes a clinical benefit and financial safeguard. Trella Health enables providers to move from philosophy to proof.
Want to learn more about Trella Health’s Hospice Timing Impact metrics? Watch this on-demand webinar for a live demo.
How Does Trella Health Support Preferred Provider Positioning?
Under LEAD, “Preferred Provider” status will become increasingly competitive.
ACOs will evaluate partners based on measurable cost containment and quality impact, not historical relationships. CMS Administered Risk Arrangements (CARA) will enable episode-based risk arrangements between ACOs and their specialists to facilitate greater and stronger preferred provider relationships.
Trella Health equips providers to:
- Identify high-value hospital and physician partners
- Bring data-backed performance evidence into network discussions
- Highlight areas where competitors drive higher utilization
- Strategically align sales and clinical education efforts
- Support care coordination and the development of episode-based risk arrangements through data sharing and analytics
Rather than waiting to be evaluated, providers can proactively shape the narrative with objective claims data. That changes negotiating power.
What Makes Trella Health Uniquely Positioned for the LEAD Era?
Trella Health combines three capabilities essential for LEAD success:
- Patient-Level Claims Transparency: Granular visibility into Medicare spend, utilization, and referral behavior.
- Market and Competitive Benchmarking: Clear insight into how an organization performs relative to peers.
- Strategic Sales Enablement: Visualizations that translate analytics into compelling value conversations.
The LEAD model supports provider organizations and primary care providers through innovative payment models such as capitated payments and prospective payments, aiming to provide long-term financial stability, especially for rural or independent practices.
In a risk-bearing environment, insight becomes influence. Trella bridges the gap between clinical impact and financial accountability.
What Happens to Providers Without This Visibility?
As CMS pushes risk downstream:
- Referral networks will narrow. Reducing hospital readmissions is crucial for patient well-being, financial implications, and resource optimization.
- Performance scrutiny will intensify
- Contracts will favor measurable cost reducers
Hospital readmissions can pose significant challenges for both healthcare providers and patients, leading to rising healthcare costs and straining resources.
Providers unable to quantify their impact may find themselves excluded, not because of poor care, but because of invisible value.
Under LEAD, invisibility equals vulnerability.
The Bottom Line: LEAD Is a Data-Driven Era and Trella Health Is the Enabler
The CMS LEAD Model cements a decade-long commitment to value-based accountability. LEAD also aims to support the integration of Medicare and Medicaid services, particularly for dually eligible beneficiaries. The model will create incentives for Medicare and Medicaid health care providers to coordinate care and improve outcomes for these beneficiaries.
For post-acute providers, the strategic mandate is clear:
- Demonstrate lower total cost of care
- Quantify Days at Home impact
- Prove readmission reduction
- Show measurable hospice timing benefits
Trella Health empowers organizations to do exactly that. In a market where preferred status depends on proof, the differentiator will not be who markets the loudest; it will be who can validate their value with data. Under LEAD, proof wins.
Connect with a Trella Health product expert today to learn m
